|
(February 14, 2008) Lyon, France — Yole Développement, a market research and strategy consulting company, has released a report on how microelectronics can bring added value to life sciences applications. The key challenge for microelectronics is to make complexity invisible and adapt it to the value chain and standard operations of the life science industries.
Microsystems technologies are changing the life sciences industry. New in-vitro diagnostic systems, new therapy strategies, genetic disease treatment, targeted and intelligent drug delivery, artificial pancreas, and drug discovery processes are healthcare improvements promised to future generations and enabled by semiconductor and MEMS technologies. The life sciences industry already faces critical challenges in addressing this expected market.
To take part in this innovation process, it is very important to understand the technology and industrial trends by having a good knowledge of currently used technologies, their limits and advantages, their applications and the way the life sciences industry currently works. It is a broad field including industries like drug discovery, in-vitro diagnostics, medical devices, and instrumentation. In the same way, the market is segmented by applications, technologies and specific medical use.
For more information, go to Yole's web site at www.yole.fr, or contact the author, Frédéric Breussin at e-mail Breussin@yole.fr.
|
Web Exclusives 
Add RSS Feed
